Sanara Medtech Inc
NASDAQ:SMTI
Sanara Medtech Inc
Cash from Operating Activities
Sanara Medtech Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sanara Medtech Inc
NASDAQ:SMTI
|
Cash from Operating Activities
-$3.2m
|
CAGR 3-Years
7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-6%
|
|
Haemonetics Corp
NYSE:HAE
|
Cash from Operating Activities
$197.4m
|
CAGR 3-Years
9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
|
Cooper Companies Inc
NYSE:COO
|
Cash from Operating Activities
$563.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
3%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash from Operating Activities
$377m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-1%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash from Operating Activities
$785.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
See Also
What is Sanara Medtech Inc's Cash from Operating Activities?
Cash from Operating Activities
-3.2m
USD
Based on the financial report for Dec 31, 2023, Sanara Medtech Inc's Cash from Operating Activities amounts to -3.2m USD.
What is Sanara Medtech Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-6%
Over the last year, the Cash from Operating Activities growth was 42%. The average annual Cash from Operating Activities growth rates for Sanara Medtech Inc have been 7% over the past three years , and -6% over the past ten years .